despropionylfentanyl: metabolite of fentanyl; RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 88890 |
| SCHEMBL ID | 916913 |
| MeSH ID | M0214215 |
| Synonym |
|---|
| 4-piperidinamine, n-phenyl-1-(2-phenylethyl)- |
| OPREA1_282173 |
| EU-0037135 |
| OPREA1_665756 |
| despropionylfentanyl |
| 21409-26-7 |
| 1-phenethyl-n-phenylpiperidin-4-amine |
| 4-anilino-1-phenethylpiperidine |
| unii-q88ehd0u8g |
| 4-anilino-n-phenethyl-4-piperidine |
| q88ehd0u8g , |
| anpp |
| dea no. 8333 |
| AM62697 |
| FT-0673808 |
| AKOS008969276 |
| n-phenyl-1-(2-phenylethyl)-4-piperidinamine |
| depropionylfentanyl |
| n-(1-phenethyl-piperidin-4-yl)-aniline |
| n-phenyl-1-(2-phenethyl)piperidin-4-amine |
| 4-anpp |
| fentanyl impurity d [ep impurity] |
| fentanyl citrate impurity d [ep impurity] |
| n-(1-(2-phenylethyl)-4-piperidinyl)aniline |
| anpp ( precursor to fentanyl) |
| 4-anilino-1-(2-phenethyl)piperidine |
| 4-anilino-1-(.beta.-phenethyl)piperidine |
| despropionyl fentanyl |
| n-phenyl-1-(2-phenylethyl)piperidin-4-amine |
| n-(1-phenethyl-4-piperidinyl)-phenylamine |
| 4-anilino-n-phenethyl-piperidine |
| 4-anilino n-phenethyl piperidine |
| SCHEMBL916913 |
| n-phenyl-1-(2-phenylethyl)-4-piperidinamine # |
| 4-anilino-n-phenethylpiperidine |
| AC-25832 |
| DTXSID40175680 |
| n-[1-(2-phenylethyl)-4-piperidinyl]benzenamine |
| CS-D0504 |
| BCP25261 |
| AS-38214 |
| Q27287105 |
| discontinued see: a625875 |
| n-phenyl-n'-[1-(2-phenylethyl)]-4-piperidine |
| PD017040 |
| mfcd00179023 |
| 1-phenethyl-n-phenyl-piperidin-4-amine |
| Excerpt | Reference | Relevance |
|---|---|---|
| " To facilitate pharmacokinetic studies of fentanyl and its metabolites in neonates and other children, we developed and validated an LC-MS/MS method based on minimally invasive, low blood volume sampling." | ( A low blood volume LC-MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children. Christians, U; Clavijo, CF; Cromie, M; Galinkin, JL; Hoffman, KL; Schniedewind, B; Thomas, JJ, 2011) | 0.37 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.86) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||